相关实验视频

Updated: Jul 1, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

卡西塔斯B细胞淋巴瘤-B (Cbl-b):小分子免疫治疗的新治疗途径

Xiuqi Hu¹, Erdong Li¹, Yangguo Zhou¹

¹State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Bioorganic & medicinal chemistry

|March 8, 2024

概括

卡西塔斯B细胞淋巴瘤-b (Cbl-b) 是癌症免疫治疗的有希望的目标. 小分子Cbl-b抑制剂显示出激活免疫监测和增强抗瘤功效的潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

免疫疗法改变了癌症治疗,越来越需要针对细胞内通路的药物.
卡西塔斯B细胞淋巴瘤-b (Cbl-b) 是E3泛基因酶,是免疫细胞激活的关键调节者.
Cbl-b限制了先天性和适应性免疫反应,使其成为新型癌症治疗的重要目标.

研究的目的:

审查在癌症免疫治疗中准Cbl-b的生物学理由.
总结一下Cbl-b抑制剂研究的最新进展.
要突出Cbl-b的全性小分子抑制剂.

主要方法:

对Cbl-b抑制剂的临床前和临床研究的文献综述.
分析Cbl-b在免疫调节和抗瘤活性中的作用.
专注于小分子Cbl-b抑制剂的发展和作用机制.

主要成果:

Cbl-b 抑制剂在激活免疫监测方面显示出显著的潜力.
这些抑制剂在临床前模型中显示出有希望的抗瘤疗效.
一些Cbl-b抑制剂已经进入I期临床试验.

结论:

对于开发下一代癌症免疫疗法来说,Cbl-b是一个可行的,有前途的细胞内标.
菌小分子抑制剂是Cbl-b向治疗的关键开发领域.
需要进一步的研究和临床评估,才能充分实现Cbl-b抑制的治疗潜力.

关键词:

艾洛斯特抑制剂艾洛斯特抑制剂在Cbl-bb中使用.E3 结合酶的使用免疫治疗是一种免疫疗法.细胞内免疫治疗的点是细胞内免疫疗法.小分子分子小分子分子

更多相关视频

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...